Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 5 | Mind Blowing Facts

North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now.

As policy meets potential in North Carolina, Atai Life Sciences could be a solid portfolio addition now.

Barchart

Intel Returns To Profitability On Stronger AI-Driven Demand, These Analysts Raise Price Targets

Shares of Intel Corp (NASDAQ:INTC) climbed in early trading on Friday, after the company reported upbeat third-quarter results.

Benzinga

Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst

On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tesla Stock Has 'Limited Valuation Support': Analysts See Near-Term Risks After Q3 Results

Tesla Inc. (NASDAQ:TSLA) analysts see near-term risks and pressure for the stock after mixed third-quarter results and new updates on product launch timelines.

Benzinga

Salesforce Targets $60 Billion Revenue By 2030: Why Analysts See Room For Margin Expansion

Salesforce Inc (NYSE:CRM) shares rallied in early trading on Thursday, after the company set a revenue target of $60 billion for fiscal 2030.

Benzinga

This Analyst Nearly Doubled His Price Target on 1 Data Center Stock. Should You Buy It Now?

Applied Digital stock jumped 27% after a Needham analyst nearly doubled his price target on strong Q1 results, but it's now trading well above the consensus target, suggesting optimism is high and future gains may be modest.

Barchart

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression

Needham initiated coverage on Mind Medicine Inc. (NASDAQ:MNMD), or MindMed, on Monday. The late-stage clinical biopharmaceutical company is developing novel product candidates to treat brain health disorders.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside

Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health.

Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst

Needham initiated coverage on Monday for GH Research PLC (NASDAQ:GHRS), citing the company’s lead drug candidate, GH-001, which had demonstrated impressive efficacy in Phase 2 versus competition.

Benzinga

Bitcoin Miner CleanSpark To Begin Building HPC Pipeline, Analyst Raises Price Target

Bitcoin mining company CleanSpark Inc (NASDAQ:CLSK) seems "serious" about building an HPC (high-performance computing) pipeline, according to Needham.

Benzinga

Levi Strauss Stock Tanking After Q3 Is Buying Opportunity, Says Analyst

Levi Strauss Co (NYSE:LEVI) shares tanked in early trading on Friday, even after the company reported upbeat third-quarter earnings.

Benzinga

Why This Applied Digital Analyst Doubles Price Target

After Applied Digital Corp (NASDAQ:APLD) reported stronger-than-expected quarterly revenues on after the market closed on Thursday, the focus has shifted to Polaris Forge 2 (PF-2), according to Needham.

Benzinga

1 Million Reasons to Buy KLAR Stock After the Klarna IPO

Klarna just announced that over 1 million Americans have signed up for its new card.

Barchart

Equifax Locks In $4.50 VantageScore Pricing Through 2027, Analyst Sees Updside

Equifax Inc's (NYSE:EFX) recently announced pricing for VantageScore® 4.0 mortgage credit scores is likely to preserve the company's unit economics, according to Needham.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Red Cat Stock Gets Bullish Analyst Call As Drone Supercycle Takes Off

The unmanned aerial systems (UAS) industry is entering "a multi-year supercycle" and Red Cat Holdings Inc (NASDAQ:RCAT) is "uniquely positioned" to benefit from accelerating demand for defense-grade small ISR drones, according to Needham.

Benzinga

General Motors To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

CarMax Hits Speedbump: Analysts Slash Price Targets Citing 'Inventory Mismanagement,' Low Demand

Used-car retail giant CarMax Inc (NYSE: KMX) on Thursday reported disappointing second-quarter results.

Benzinga

Tesla To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Lululemon Analyst Is No Longer Bullish Due To Business Decline, Tariffs, Competition

While a turnaround in Lululemon Athletica Inc's (NASDAQ: LULU) U.S. business seemed likely last year, the momentum did not continue into 2025, according to Needham.

Benzinga

Micron Technology Smashes Q4 Estimates, Pricing Drives GM Outlook; Analysts Raise Price Target

Shares of Micron Technology Inc (NASDAQ:MU) dipped in early trading on Wednesday despite a strong fiscal fourth quarter report.

Barchart

Can IONQ Stock Reach $80 in 2025?

IonQ’s ambitious roadmap and Needham’s new Street-high target signal growing momentum.

Benzinga

Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

AppLovin To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

General Motors To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.